Share
The pharma industry briefing
The latest news, approvals and clinical trials you need to know about this month
Data:
News in Numbers
Data: News in Numbers
$2.2bn
Royalty Pharma is set to sell $2.2bn of its shares in the biggest US listing of this year.
10%
The global drug discovery outsourcing market is expected to garner a CAGR of 10% during 2020 – 2030.
10%
400 million
AstraZeneca has signed an agreement to supply 400 million doses of Covid-19 vaccine to Europe.
18
The number of over-the-counter and prescription drugs marketed in the Asia-Pacific region that Takeda has sold to South Korea’s Celltrion.
300
The number of healthy participants set to be immunised with two doses of the Covid-19 vaccine candidate developed at Imperial College London.
Data: News in Numbers
$2.2bn
Royalty Pharma is set to sell $2.2bn of its shares in the biggest US listing of this year.
10%
The global drug discovery outsourcing market is expected to garner a CAGR of 10% during 2020 – 2030.
18
The number of over-the-counter and prescription drugs marketed in the Asia-Pacific region Takeda has sold to South Korea’s Celltrion.
400 million
AstraZeneca has signed an agreement to supply 400 million doses of Covid-19 vaccine to Europe.
300
The number of healthy participants set to be immunised with two doses of the Covid-19 vaccine candidate developed at Imperial College London.
Evidence builds for use of MDMA as PTSD therapy
MDMA has become notorious as an illegal dance drug – but the evidence supporting its approval as a treatment for post-traumatic stress disorder in combination with psychotherapy is mounting.
Source: Pharmaphorum
Dexamethasone proves first life-saving drug
The low-dose steroid treatment dexamethasone is a major breakthrough in the fight against Covid-19, UK experts say.
Source: BBC
FDA revokes emergency approval of malaria drugs
The agency said that a review of some studies showed that the drugs’ potential benefits in treating Covid-19 did not outweigh the risks.
Source: New York Times
UK post-Brexit drug stockpiles at risk amid virus
The UK has been warned by the pharmaceutical industry that some stockpiles of medical supplies have been "used up entirely" by the virus.
Source: BBC
Approvals
Lyumjev (insulin lispro-aabc) Injection
The US Food and Drug Administration (FDA) has approved Lyumjev (insulin lispro-aabc), a rapid-acting human insulin analog indicated to improve glycemic control in adults with diabetes mellitus.
Source: Pharmaceutical Technology
Dolutegravir,
Tivicay PD
The US FDA has approved ViiV Healthcare’s dispersible tablet formulation of dolutegravir, Tivicay PD, a once-daily treatment for children living with HIV.
Source: Business Wire
Austedo
Teva Pharmaceutical has received approval from China for its Austedo treatment for Huntington’s disease.
Source: Reuters
Ethacrynate Sodium
Valeo Pharma, a Canadian specialty pharmaceutical company, has received approval for its Abbreviated New Drug Application from the US FDA for Ethacrynate Sodium 50mg.
Source: Valeo Pharma
Go to top
Go to top
Share this article
